CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
G
Chrna2
cholinergic receptor nicotinic alpha 2 subunit
multiple interactions
ISO EXP
Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA2 protein] 1,1-dimethyl-4-phenylpiperazinium iodide affects binding competes with [Epibatidine binds to Chrna2 protein]
CTD RGD
PMID:9454827 PMID:15016836
RGD:2303194
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
ISO EXP
Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA3 protein] 1,1-dimethyl-4-phenylpiperazinium iodide affects binding [Epibatidine binds to Chrna3 protein]
CTD RGD
PMID:9454827 PMID:15016836
RGD:2303194
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
ISO EXP
Dimethylphenylpiperazinium Iodide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA4 protein] 1,1-dimethyl-4-phenylpiperazinium iodide affects binding to Chrna4 protein; 1,1-dimethyl-4-phenylpiperazinium iodide competes with [Epibatidine binds to Chrna4 protein]
CTD RGD
PMID:9454827 PMID:14645658 PMID:15016836
RGD:2303194
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions increases response to substance increases activity
ISO
Dimethylphenylpiperazinium Iodide inhibits the reaction [Bungarotoxins binds to CHRNA7 protein] CHRNA7 protein mutant form results in increased susceptibility to Dimethylphenylpiperazinium Iodide Dimethylphenylpiperazinium Iodide results in increased activity of CHRNA7 protein
CTD
PMID:10082212 PMID:10216184
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO EXP
Dimethylphenylpiperazinium Iodide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] 1,1-dimethyl-4-phenylpiperazinium iodide affects binding to Chrnb2 protein; 1,1-dimethyl-4-phenylpiperazinium iodide competes with [Epibatidine binds to Chrnb2 protein]
CTD RGD
PMID:14645658 PMID:15016836
RGD:2303194
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
multiple interactions
ISO
Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]
CTD
PMID:9454827
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
G
Tnf
tumor necrosis factor
increases activity
EXP
TNF results in increased activity of Dimethylphenylpiperazinium Iodide
CTD
PMID:15086448
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Chrm3
cholinergic receptor, muscarinic 3
affects binding
IDA
4-DAMP methiodide inhibits response to acetylcholine in rat aortic rings
RGD
PMID:8075871
RGD:2303390
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Abca4
ATP binding cassette subfamily A member 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ABCA4 mRNA
CTD
PMID:36706583
NCBI chr 2:210,164,813...210,302,069
Ensembl chr 2:210,164,813...210,302,069
G
Abcc6
ATP binding cassette subfamily C member 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ABCC6 mRNA
CTD
PMID:36706583
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
G
Acox2
acyl-CoA oxidase 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ACOX2 mRNA
CTD
PMID:36706583
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ACTA2 mRNA
CTD
PMID:36706583
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adamts19
ADAM metallopeptidase with thrombospondin type 1 motif, 19
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of ADAMTS19 mRNA
CTD
PMID:36706583
NCBI chr18:52,346,448...52,531,245
Ensembl chr18:52,347,428...52,530,509
G
Adrb3
adrenoceptor beta 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ADRB3 mRNA
CTD
PMID:36706583
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ALDH1A1 mRNA
CTD
PMID:36706583
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
multiple interactions
EXP
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of ALDH1L1 protein
CTD
PMID:30090431
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
multiple interactions
EXP
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of ALDH5A1 protein
CTD
PMID:30090431
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Angptl2
angiopoietin-like 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ANGPTL2 mRNA
CTD
PMID:36706583
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
G
Anxa8
annexin A8
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of ANXA8 mRNA
CTD
PMID:36706583
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Apobec1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of APOBEC1 mRNA
CTD
PMID:36706583
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
G
Aqp1
aquaporin 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of AQP1 mRNA
CTD
PMID:36706583
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Art3
ADP-ribosyltransferase 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ART3 mRNA
CTD
PMID:36706583
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Diatrizoate co-treated with Iodine] results in increased expression of BAX protein
CTD
PMID:17173243
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein
CTD
PMID:17173243
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
C1qtnf2
C1q and TNF related 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of C1QTNF2 mRNA
CTD
PMID:36706583
NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185
G
Calml4
calmodulin-like 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CALML4 mRNA
CTD
PMID:36706583
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Casp3
caspase 3
multiple interactions
ISO
[Diatrizoate co-treated with Iodine] results in increased activity of CASP3 protein
CTD
PMID:17173243
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cbr2
carbonyl reductase 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CBR2 mRNA
CTD
PMID:36706583
NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
G
Cck
cholecystokinin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CCK mRNA
CTD
PMID:36706583
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Ccl28
C-C motif chemokine ligand 28
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CCL28 mRNA
CTD
PMID:36706583
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CCL3 mRNA
CTD
PMID:36706583
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccn2
cellular communication network factor 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CCN2 mRNA
CTD
PMID:36706583
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Cd274
CD274 molecule
increases expression multiple interactions
ISO
Iodine results in increased expression of CD274 mRNA CD274 protein affects the reaction [Iodine results in increased expression of PDCD1 mRNA]; CD274 protein affects the reaction [Iodine results in increased expression of PDCD1 protein]; CD274 protein affects the reaction [Iodine results in increased expression of PDCD1LG2 mRNA]
CTD
PMID:37598415
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd79a
CD79a molecule
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CD79A mRNA
CTD
PMID:36706583
NCBI chr 1:80,493,581...80,497,936
Ensembl chr 1:80,493,581...80,497,935
G
Cd86
CD86 molecule
increases expression
EXP
Iodine results in increased expression of CD86 mRNA
CTD
PMID:19035182
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdh23
cadherin-related 23
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CDH23 mRNA
CTD
PMID:36706583
NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419
G
Cdh3
cadherin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CDH3 mRNA
CTD
PMID:36706583
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
decreases expression
EXP
Iodine deficiency results in decreased expression of CDK5R1 protein
CTD
PMID:22987596
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Ceacam4
CEA cell adhesion molecule 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CEACAM10 mRNA
CTD
PMID:36706583
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
G
Cibar2
CBY1 interacting BAR domain containing 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAM92B mRNA
CTD
PMID:36706583
NCBI chr19:48,217,617...48,229,418
Ensembl chr19:48,215,486...48,229,404
G
Cimip2c
ciliary microtubule inner protein 2C
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAM166C mRNA
CTD
PMID:36706583
NCBI chr 6:25,905,294...25,923,615
Ensembl chr 6:25,905,294...25,923,615
G
Clcn5
chloride voltage-gated channel 5
increases abundance increases uptake
ISO
CLCN5 gene mutant form results in increased abundance of Iodine CLCN5 gene mutant form results in increased uptake of Iodine
CTD
PMID:16306076
NCBI chr X:15,185,380...15,339,977
Ensembl chr X:15,185,451...15,334,264
G
Cldn2
claudin 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CLDN2 mRNA
CTD
PMID:36706583
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
G
Cldn5
claudin 5
multiple interactions
ISO
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein; [gamma-Linolenic Acid co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; Iodine results in increased expression of and results in increased localization of CLDN5 protein
CTD
PMID:16514648
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Clec7a
C-type lectin domain containing 7A
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CLEC7A mRNA
CTD
PMID:36706583
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Iodine results in increased expression of COL1A1 mRNA
CTD
PMID:22083529
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col24a1
collagen type XXIV alpha 1 chain
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of COL24A1 mRNA
CTD
PMID:36706583
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
G
Col4a3
collagen type IV alpha 3 chain
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of COL4A3 mRNA
CTD
PMID:36706583
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
G
Col8a1
collagen type VIII alpha 1 chain
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of COL8A1 mRNA
CTD
PMID:36706583
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of COLQ mRNA
CTD
PMID:36706583
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Cort
cortistatin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CORT mRNA
CTD
PMID:36706583
NCBI chr 5:159,560,591...159,562,032
G
Cplx3
complexin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CPLX3 mRNA
CTD
PMID:36706583
NCBI chr 8:58,003,535...58,010,297
Ensembl chr 8:58,003,535...58,010,297
G
Cpz
carboxypeptidase Z
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CPZ mRNA
CTD
PMID:36706583
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
G
Crhr2
corticotropin releasing hormone receptor 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of CRHR2 mRNA
CTD
PMID:36706583
NCBI chr 4:84,222,897...84,265,924
Ensembl chr 4:84,224,002...84,265,904
G
Crygn
crystallin, gamma N
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CRYGN mRNA
CTD
PMID:36706583
NCBI chr 4:10,394,015...10,401,542
Ensembl chr 4:10,394,020...10,401,543
G
Cth
cystathionine gamma-lyase
multiple interactions
EXP
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of CTH protein
CTD
PMID:30090431
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Cwh43
cell wall biogenesis 43 C-terminal homolog
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CWH43 mRNA
CTD
PMID:36706583
NCBI chr14:34,754,279...34,800,530
Ensembl chr14:34,754,289...34,800,814
G
Cyb5a
cytochrome b5 type A
multiple interactions
EXP
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of CYB5A protein
CTD
PMID:30090431
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CYP11A1 mRNA
CTD
PMID:36706583
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CYP19A1 mRNA
CTD
PMID:36706583
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[Iodine deficiency co-treated with Propylthiouracil] results in increased expression of CYP2B10 mRNA
CTD
PMID:22503787
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2f4
cytochrome P450, family 2, subfamily f, polypeptide 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CYP2F2 mRNA
CTD
PMID:36706583
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
G
Depp1
DEPP autophagy regulator 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DEPP1 mRNA
CTD
PMID:36706583
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Dio1
iodothyronine deiodinase 1
decreases activity multiple interactions increases expression decreases expression
ISO EXP
Iodine results in decreased activity of DIO1 protein Methylnitrosourea inhibits the reaction [Iodine results in increased expression of DIO1 mRNA] Selenium inhibits the reaction [Iodine results in decreased activity of DIO1 protein]; Selenium inhibits the reaction [Iodine results in decreased expression of DIO1 mRNA]
CTD
PMID:15922087 PMID:17044649
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dio3
iodothyronine deiodinase 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DIO3 mRNA
CTD
PMID:36706583
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
G
Dio3os
DIO3 opposite strand upstream RNA
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DIO3OS mRNA
CTD
PMID:36706583
G
Dmbt1l1
deleted in malignant brain tumors 1 like 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of CDCP3 mRNA
CTD
PMID:36706583
NCBI chr 1:185,949,897...186,084,340
Ensembl chr 1:185,949,881...186,084,338
G
Dmkn
dermokine
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DMKN mRNA
CTD
PMID:36706583
NCBI chr 1:86,013,237...86,031,243
Ensembl chr 1:86,014,188...86,030,006
G
Dmrt2
doublesex and mab-3 related transcription factor 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DMRT2 mRNA
CTD
PMID:36706583
NCBI chr 1:223,317,543...223,324,131
Ensembl chr 1:223,317,642...223,324,131
G
Drd3
dopamine receptor D3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DRD3 mRNA
CTD
PMID:36706583
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Dsc3
desmocollin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DSC3 mRNA
CTD
PMID:36706583
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Dthd1
death domain containing 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of DTHD1 mRNA
CTD
PMID:36706583
NCBI chr14:46,670,438...46,673,183
G
Edaradd
EDAR associated via death domain
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of EDARADD mRNA
CTD
PMID:36706583
NCBI chr17:85,866,629...85,910,612
Ensembl chr17:85,656,905...85,910,447
G
Edn3
endothelin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EDN3 mRNA
CTD
PMID:36706583
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
G
Emx1
empty spiracles homeobox 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EMX1 mRNA
CTD
PMID:36706583
NCBI chr 4:117,725,148...117,741,616
Ensembl chr 4:117,725,155...117,741,613
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ENPP2 mRNA
CTD
PMID:36706583
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Epn3
epsin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EPN3 mRNA
CTD
PMID:36706583
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
G
F5
coagulation factor V
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of F5 mRNA
CTD
PMID:36706583
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Fam180a
family with sequence similarity 180, member A
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAM180A mRNA
CTD
PMID:36706583
NCBI chr 4:63,992,867...64,008,047
Ensembl chr 4:63,992,867...64,008,047
G
Fap
fibroblast activation protein, alpha
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAP mRNA
CTD
PMID:36706583
NCBI chr 3:47,138,823...47,207,671
Ensembl chr 3:47,138,813...47,225,545
G
Fat2
FAT atypical cadherin 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FAT2 mRNA
CTD
PMID:36706583
NCBI chr10:39,364,072...39,456,324
Ensembl chr10:39,364,073...39,456,216
G
Fbn2
fibrillin 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of FBN2 mRNA
CTD
PMID:36706583
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
G
Fbxl22
F-box and leucine-rich repeat protein 22
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FBXL22 mRNA
CTD
PMID:36706583
NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685
G
Fezf2
Fez family zinc finger 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FEZF2 mRNA
CTD
PMID:36706583
NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554
G
Fgf7
fibroblast growth factor 7
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FGF7 mRNA
CTD
PMID:36706583
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Folr1
folate receptor alpha
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of FOLR1 mRNA
CTD
PMID:36706583
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
EXP
Iodine results in increased expression of FOS mRNA; Iodine results in increased expression of FOS protein [Selenium co-treated with Iodine] results in increased expression of FOS mRNA; [Selenium co-treated with Iodine] results in increased expression of FOS protein
CTD
PMID:12475444 PMID:12666833
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Frmd7
FERM domain containing 7
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of FRMD7 mRNA
CTD
PMID:36706583
NCBI chr X:130,375,925...130,423,836
Ensembl chr X:130,377,227...130,423,771
G
Ftcd
formimidoyltransferase cyclodeaminase
multiple interactions
EXP
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of FTCD protein
CTD
PMID:30090431
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
G
Gamt
guanidinoacetate N-methyltransferase
multiple interactions
EXP
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of GAMT protein
CTD
PMID:30090431
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
G
Gbp4
guanylate binding protein 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GBP3 mRNA
CTD
PMID:36706583
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gjb6
gap junction protein, beta 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GJB6 mRNA
CTD
PMID:36706583
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
G
Gkn3
gastrokine 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GKN3 mRNA
CTD
PMID:36706583
NCBI chr 4:119,828,859...119,833,924
Ensembl chr 4:119,829,005...119,834,842
G
Gli1
GLI family zinc finger 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GLI1 mRNA
CTD
PMID:36706583
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gls2
glutaminase 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GLS2 mRNA
CTD
PMID:36706583
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
G
Gypa
glycophorin A
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of GYPA mRNA
CTD
PMID:36706583
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
G
Hdc
histidine decarboxylase
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HDC mRNA
CTD
PMID:36706583
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hhatl
hedgehog acyltransferase-like
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HHATL mRNA
CTD
PMID:36706583
NCBI chr 8:121,447,001...121,454,070
Ensembl chr 8:121,447,002...121,454,001
G
Hkdc1
hexokinase domain containing 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HKDC1 mRNA
CTD
PMID:36706583
NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of HSD11B1 mRNA
CTD
PMID:36706583
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Ibsp
integrin-binding sialoprotein
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of IBSP mRNA
CTD
PMID:36706583
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
G
Ifng
interferon gamma
multiple interactions increases expression
EXP ISO
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IFNG protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IFNG protein] Iodine results in increased expression of IFNG protein
CTD
PMID:29385629 PMID:37598415
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igfbp6
insulin-like growth factor binding protein 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of IGFBP6 mRNA
CTD
PMID:36706583
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
G
Il17a
interleukin 17A
multiple interactions increases expression
EXP ISO
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL17A protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL17A protein] Iodine results in increased expression of IL17A protein
CTD
PMID:29385629 PMID:37598415
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
multiple interactions
EXP
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL1B protein
CTD
PMID:29385629
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
increases expression
EXP ISO
Iodine results in increased expression of IL2 protein
CTD
PMID:19035182 PMID:37598415
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
multiple interactions
EXP
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein]
CTD
PMID:29385629
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Impg1
interphotoreceptor matrix proteoglycan 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of IMPG1 mRNA
CTD
PMID:36706583
NCBI chr 8:81,243,624...81,389,722
Ensembl chr 8:81,243,624...81,389,722
G
Irx5
iroquois homeobox 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of IRX5 mRNA
CTD
PMID:36706583
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
G
Isg20
interferon stimulated exonuclease gene 20
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ISG20 mRNA
CTD
PMID:36706583
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ITIH3 mRNA
CTD
PMID:36706583
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
EXP
Iodine results in increased expression of JUN mRNA; Iodine results in increased expression of JUN protein [Iodine co-treated with Dibutyl Phthalate] results in increased phosphorylation of and results in increased activity of JUN protein; [Selenium co-treated with Iodine] results in increased expression of JUN mRNA; [Selenium co-treated with Iodine] results in increased expression of JUN protein
CTD
PMID:12475444 PMID:12666833 PMID:29385629
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kcne2
potassium voltage-gated channel subfamily E regulatory subunit 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of KCNE2 mRNA
CTD
PMID:36706583
NCBI chr11:31,517,176...31,530,026
Ensembl chr11:31,295,614...31,530,043
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of KCNJ10 mRNA
CTD
PMID:36706583
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
Kcnj13
potassium inwardly-rectifying channel, subfamily J, member 13
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of KCNJ13 mRNA
CTD
PMID:36706583
NCBI chr 9:88,063,003...88,071,112
Ensembl chr 9:88,063,003...88,071,112
G
Kl
Klotho
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of KL mRNA
CTD
PMID:36706583
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Klhl1
kelch-like family member 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of KLHL1 mRNA
CTD
PMID:36706583
NCBI chr15:72,698,191...73,142,726
Ensembl chr15:72,699,094...73,142,594
G
Krt18
keratin 18
multiple interactions
EXP
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of KRT18 protein
CTD
PMID:30090431
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Lbp
lipopolysaccharide binding protein
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of LBP mRNA
CTD
PMID:36706583
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lemd1
LEM domain containing 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LEMD1 mRNA
CTD
PMID:36706583
NCBI chr13:43,631,705...43,697,765
Ensembl chr13:43,665,926...43,697,948
G
Lep
leptin
multiple interactions
EXP
[Iodine deficiency co-treated with sodium perchlorate] results in increased secretion of LEP protein
CTD
PMID:30090431
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LGR5 mRNA
CTD
PMID:36706583
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
[Iodine deficiency co-treated with sodium perchlorate] results in decreased secretion of LHB protein
CTD
PMID:30090431
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Loxl1
lysyl oxidase-like 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of LOXL1 mRNA
CTD
PMID:36706583
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lrp1
LDL receptor related protein 1
multiple interactions
ISO
[Iodine deficiency co-treated with Propylthiouracil] results in decreased expression of LRP1 protein; Triiodothyronine inhibits the reaction [[Iodine deficiency co-treated with Propylthiouracil] results in decreased expression of LRP1 protein]
CTD
PMID:23517243
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Lrp2
LDL receptor related protein 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of LRP2 mRNA
CTD
PMID:36706583
NCBI chr 3:54,189,305...54,346,769
Ensembl chr 3:54,189,308...54,346,708
G
Ly6a
lymphocyte antigen 6 family member A
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of LY6A mRNA
CTD
PMID:36706583
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
G
Map1b
microtubule-associated protein 1B
decreases expression
EXP
Iodine deficiency results in decreased expression of MAP1B protein
CTD
PMID:27444543
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
G
Mbp
myelin basic protein
decreases expression multiple interactions
ISO
Iodine results in decreased expression of MBP mRNA Selenium inhibits the reaction [Iodine results in decreased expression of MBP mRNA]
CTD
PMID:16229266
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mc3r
melanocortin 3 receptor
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of MC3R mRNA
CTD
PMID:36706583
NCBI chr 3:161,016,347...161,017,444
Ensembl chr 3:161,016,347...161,017,444
G
Mfap4
microfibril associated protein 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MFAP4 mRNA
CTD
PMID:36706583
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
G
Mfrp
membrane frizzled-related protein
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MFRP mRNA
CTD
PMID:36706583
NCBI chr 8:44,445,636...44,450,859
Ensembl chr 8:44,445,697...44,450,859
G
Mgp
matrix Gla protein
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MGP mRNA
CTD
PMID:36706583
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mirlet7bhg
Mirlet7b host gene
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LNCPPARA mRNA
CTD
PMID:36706583
G
Misp3
MISP family member 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MISP3 mRNA
CTD
PMID:36706583
NCBI chr19:24,139,998...24,142,006
Ensembl chr19:24,140,033...24,142,631
G
Msx1
msh homeobox 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MSX1 mRNA
CTD
PMID:36706583
NCBI chr14:72,961,036...72,964,970
Ensembl chr14:72,961,148...72,964,966
G
Mybpc3
myosin binding protein C3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MYBPC3 mRNA
CTD
PMID:36706583
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
G
Myh3
myosin heavy chain 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MYH3 mRNA
CTD
PMID:36706583
NCBI chr10:51,770,177...51,793,994
Ensembl chr10:51,770,177...51,793,992
G
Myl4
myosin, light chain 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MYL4 mRNA
CTD
PMID:36706583
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
G
Myot
myotilin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of MYOT mRNA
CTD
PMID:36706583
NCBI chr18:36,705,244...36,724,849
Ensembl chr18:36,705,314...36,724,841
G
Ndnf
neuron-derived neurotrophic factor
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NDNF mRNA
CTD
PMID:36706583
NCBI chr 4:94,944,392...94,981,871
Ensembl chr 4:94,944,360...94,981,873
G
Neurod1
neuronal differentiation 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NEUROD1 mRNA
CTD
PMID:36706583
NCBI chr 3:64,359,554...64,363,526
Ensembl chr 3:64,359,395...64,363,649
G
Neurod2
neuronal differentiation 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NEUROD2 mRNA
CTD
PMID:36706583
NCBI chr10:83,323,801...83,327,986
Ensembl chr10:83,324,442...83,327,986
G
Neurod6
neuronal differentiation 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NEUROD6 mRNA
CTD
PMID:36706583
NCBI chr 4:84,846,659...84,849,905
Ensembl chr 4:84,846,231...84,849,999
G
Neurog2
neurogenin 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NEUROG2 mRNA
CTD
PMID:36706583
NCBI chr 2:216,092,709...216,095,276
Ensembl chr 2:216,093,363...216,094,154
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
Iodine deficiency results in increased expression of and results in decreased phosphorylation of NFKBIA protein
CTD
PMID:27444543
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nppc
natriuretic peptide C
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NPPC mRNA
CTD
PMID:36706583
NCBI chr 9:87,320,051...87,324,251
Ensembl chr 9:87,320,051...87,324,251
G
Nptx1
neuronal pentraxin 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NPTX1 mRNA
CTD
PMID:36706583
NCBI chr10:104,811,107...104,820,358
Ensembl chr10:104,811,403...104,820,367
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
NR1I3 protein affects the reaction [[Iodine deficiency co-treated with Propylthiouracil] results in decreased expression of CYP3A11 mRNA]
CTD
PMID:22503787
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NR4A3 mRNA
CTD
PMID:36706583
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Nrgn
neurogranin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NRGN mRNA
CTD
PMID:36706583
NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516
G
Nup62cl
nucleoporin 62 C-terminal like
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NUP62CL mRNA
CTD
PMID:36706583
NCBI chr X:103,668,458...103,724,957
Ensembl chr X:103,668,455...103,724,081
G
Nxph3
neurexophilin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NXPH3 mRNA
CTD
PMID:36706583
NCBI chr10:80,456,283...80,459,949
Ensembl chr10:80,455,429...80,462,415
G
Ocln
occludin
multiple interactions
ISO
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein; [gamma-Linolenic Acid co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; Iodine results in increased expression of and results in increased localization of OCLN protein
CTD
PMID:16514648
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Optc
opticin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of OPTC mRNA
CTD
PMID:36706583
NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237
G
Otogl
otogelin-like
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of OTOGL mRNA
CTD
PMID:36706583
NCBI chr 7:43,065,800...43,211,400
Ensembl chr 7:43,067,644...43,223,592
G
Padi6
peptidyl arginine deiminase 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PADI6 mRNA
CTD
PMID:36706583
NCBI chr 5:153,021,855...153,037,443
Ensembl chr 5:153,021,965...153,037,414
G
Paqr5
progestin and adipoQ receptor family member 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PAQR5 mRNA
CTD
PMID:36706583
NCBI chr 8:62,431,867...62,513,688
Ensembl chr 8:62,431,867...62,513,688
G
Paqr6
progestin and adipoQ receptor family member 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PAQR6 mRNA
CTD
PMID:36706583
NCBI chr 2:173,832,241...173,838,443
Ensembl chr 2:173,833,880...173,838,456
G
Pcdhb1
protocadherin beta 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of PCDHB1 mRNA
CTD
PMID:36706583
NCBI chr18:28,913,835...28,916,746
Ensembl chr18:28,913,989...28,916,445
G
Pdcd1
programmed cell death 1
increases expression multiple interactions
ISO
Iodine results in increased expression of PDCD1 mRNA; Iodine results in increased expression of PDCD1 protein CD274 protein affects the reaction [Iodine results in increased expression of PDCD1 mRNA]; CD274 protein affects the reaction [Iodine results in increased expression of PDCD1 protein]
CTD
PMID:37598415
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pdcd1lg2
programmed cell death 1 ligand 2
multiple interactions increases expression
ISO
CD274 protein affects the reaction [Iodine results in increased expression of PDCD1LG2 mRNA]
CTD
PMID:37598415
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
G
Pla2g5
phospholipase A2, group V
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PLA2G5 mRNA
CTD
PMID:36706583
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
G
Plcxd3
phosphatidylinositol-specific phospholipase C, X domain containing 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of PLCXD3 mRNA
CTD
PMID:36706583
NCBI chr 2:53,567,022...53,746,384
Ensembl chr 2:53,567,022...53,746,384
G
Pon1
paraoxonase 1
multiple interactions
EXP
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of PON1 protein; [Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of PON1 protein
CTD
PMID:30090431
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pon2
paraoxonase 2
multiple interactions
EXP
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of PON2 protein
CTD
PMID:30090431
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Prdm8
PR/SET domain 8
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PRDM8 mRNA
CTD
PMID:36706583
NCBI chr14:11,403,202...11,424,059
Ensembl chr14:11,404,407...11,410,993
G
Prickle4
prickle planar cell polarity protein 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of PRICKLE4 mRNA
CTD
PMID:36706583
NCBI chr 9:13,297,494...13,305,635
Ensembl chr 9:13,297,758...13,305,630
G
Prokr2
prokineticin receptor 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of PROKR2 mRNA
CTD
PMID:36706583
NCBI chr 3:119,624,738...119,639,442
Ensembl chr 3:119,627,601...119,635,718
G
Prr29
proline rich 29
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PRR29 mRNA
CTD
PMID:36706583
NCBI chr10:91,305,820...91,320,661
Ensembl chr10:91,305,723...91,310,439
G
Prr32
proline rich 32
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PRR32 mRNA
CTD
PMID:36706583
NCBI chr X:123,978,010...123,979,928
Ensembl chr X:123,977,985...123,979,942
G
Prss12
serine protease 12
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PRSS12 mRNA
CTD
PMID:36706583
NCBI chr 2:211,624,134...211,684,126
Ensembl chr 2:211,624,134...211,684,126
G
Ptprq
protein tyrosine phosphatase, receptor type, Q
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of PTPRQ mRNA
CTD
PMID:36706583
NCBI chr 7:42,834,455...43,016,807
Ensembl chr 7:42,837,109...43,016,917
G
Rasd2
RASD family, member 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of RASD2 mRNA
CTD
PMID:36706583
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
G
Rasl10a
RAS-like, family 10, member A
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of RASL10A mRNA
CTD
PMID:36706583
NCBI chr14:79,955,093...79,956,471
Ensembl chr14:79,954,398...79,956,468
G
Rbp2
retinol binding protein 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of RBP2 mRNA
CTD
PMID:36706583
NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Iodine deficiency results in decreased expression of and results in decreased phosphorylation of RELA protein
CTD
PMID:27444543
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Robo3
roundabout guidance receptor 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ROBO3 mRNA
CTD
PMID:36706583
NCBI chr 8:37,133,542...37,151,674
Ensembl chr 8:37,133,916...37,151,315
G
Rp1
RP1, axonemal microtubule associated
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of RP1 mRNA
CTD
PMID:36706583
NCBI chr 5:15,121,104...15,582,363
Ensembl chr 5:15,121,133...15,579,363
G
Rspo2
R-spondin 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of RSPO2 mRNA
CTD
PMID:36706583
NCBI chr 7:74,096,378...74,239,398
Ensembl chr 7:74,103,090...74,238,933
G
Rtn4rl2
reticulon 4 receptor-like 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of RTN4RL2 mRNA
CTD
PMID:36706583
NCBI chr 3:69,954,557...69,971,108
Ensembl chr 3:69,955,169...69,971,488
G
Rxfp3
relaxin family peptide receptor 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of RXFP3 mRNA
CTD
PMID:36706583
NCBI chr 2:60,003,256...60,004,686
Ensembl chr 2:60,003,256...60,004,686
G
S100a8
S100 calcium binding protein A8
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of S100A8 mRNA
CTD
PMID:36706583
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of S100A9 mRNA
CTD
PMID:36706583
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Satb2
SATB homeobox 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SATB2 mRNA
CTD
PMID:36706583
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
G
Scara5
scavenger receptor class A, member 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SCARA5 mRNA
CTD
PMID:36706583
NCBI chr15:39,880,017...39,985,007
Ensembl chr15:39,880,035...39,983,373
G
Scd
stearoyl-CoA desaturase
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SCD1 mRNA
CTD
PMID:36706583
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scn9a
sodium voltage-gated channel alpha subunit 9
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of SCN9A mRNA
CTD
PMID:36706583
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
G
Sebox
SEBOX homeobox
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEBOX mRNA
CTD
PMID:36706583
NCBI chr10:63,399,215...63,400,086
Ensembl chr10:63,399,165...63,400,606
G
Sec14l4
SEC14-like lipid binding 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEC14L4 mRNA
CTD
PMID:36706583
NCBI chr14:78,912,750...78,928,799
Ensembl chr14:78,912,750...78,956,099
G
Sema3c
semaphorin 3C
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEMA3C mRNA
CTD
PMID:36706583
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
G
Sema7a
semaphorin 7A (John Milton Hagen blood group)
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEMA7A mRNA
CTD
PMID:36706583
NCBI chr 8:58,348,448...58,370,536
Ensembl chr 8:58,348,448...58,370,536
G
Serpina7
serpin family A member 7
multiple interactions
EXP
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of SERPINA7 protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of SERPINA7 protein]
CTD
PMID:29385629
NCBI chr X:102,663,242...102,722,319
Ensembl chr X:102,663,405...102,669,040
G
Sfrp2
secreted frizzled-related protein 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of SFRP2 mRNA
CTD
PMID:36706583
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
G
Sfrp5
secreted frizzled-related protein 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SFRP5 mRNA
CTD
PMID:36706583
NCBI chr 1:241,006,762...241,011,224
Ensembl chr 1:241,006,762...241,011,224
G
Sgpp2
sphingosine-1-phosphate phosphatase 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SGPP2 mRNA
CTD
PMID:36706583
NCBI chr 9:79,762,658...79,884,665
Ensembl chr 9:79,763,284...79,880,457
G
Six2
SIX homeobox 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SIX2 mRNA
CTD
PMID:36706583
NCBI chr 6:8,974,859...8,981,345
Ensembl chr 6:8,967,157...8,981,193
G
Slc13a4
solute carrier family 13 member 4
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC13A4 mRNA
CTD
PMID:36706583
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
G
Slc17a7
solute carrier family 17 member 7
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC17A7 mRNA
CTD
PMID:36706583
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc22a3
solute carrier family 22 member 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC22A3 mRNA
CTD
PMID:36706583
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC22A6 mRNA
CTD
PMID:36706583
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc26a10
solute carrier family 26, member 10
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC26A10 mRNA
CTD
PMID:36706583
NCBI chr 7:62,995,165...63,005,099
Ensembl chr 7:62,995,381...63,004,087
G
Slc26a3
solute carrier family 26 member 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC26A3 mRNA
CTD
PMID:36706583
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
G
Slc26a4
solute carrier family 26 member 4
increases expression multiple interactions
EXP
Iodine results in increased expression of SLC26A4 mRNA Methylnitrosourea promotes the reaction [Iodine results in increased expression of SLC26A4 mRNA]
CTD
PMID:15922087
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
G
Slc27a6
solute carrier family 27 member 6
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of SLC27A6 mRNA
CTD
PMID:36706583
NCBI chr18:52,040,241...52,099,622
Ensembl chr18:52,041,074...52,099,414
G
Slc47a1
solute carrier family 47 member 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC47A1 mRNA
CTD
PMID:36706583
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
G
Slc4a5
solute carrier family 4 member 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC4A5 mRNA
CTD
PMID:36706583
NCBI chr 4:115,710,101...115,810,330
Ensembl chr 4:115,725,592...115,810,323
G
Slc5a5
solute carrier family 5 member 5
multiple interactions increases uptake affects transport
ISO EXP
2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; [[Butyrates co-treated with decitabine] results in increased expression of SLC5A5 mRNA] which results in increased uptake of Iodine; captax inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; cypermethrin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; decamethrin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; Dibutyl Phthalate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; Indomethacin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; mancozeb inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; polymarcine inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; potassium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; triclocarban inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine] SLC5A5 protein affects the transport of Iodine
CTD
PMID:12602914 PMID:17332617 PMID:17408651 PMID:17967635 PMID:27979590
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Sned1
sushi, nidogen and EGF-like domains 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SNED1 mRNA
CTD
PMID:36706583
NCBI chr 9:93,774,087...93,834,003
Ensembl chr 9:93,774,119...93,830,694
G
Sostdc1
sclerostin domain containing 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SOSTDC1 mRNA
CTD
PMID:36706583
NCBI chr 6:53,051,336...53,055,510
Ensembl chr 6:53,051,354...53,055,579
G
Sowahb
sosondowah ankyrin repeat domain family member B
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SOWAHB mRNA
CTD
PMID:36706583
NCBI chr14:15,029,203...15,033,038
Ensembl chr14:15,029,395...15,031,698
G
Spo11
SPO11 initiator of meiotic double strand breaks
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SPO11 mRNA
CTD
PMID:36706583
NCBI chr 3:161,755,299...161,770,930
Ensembl chr 3:161,757,519...161,770,925
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SPTLC3 mRNA
CTD
PMID:36706583
NCBI chr 3:126,847,878...126,978,010
Ensembl chr 3:126,847,878...126,978,010
G
Srl
sarcalumenin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SRL mRNA
CTD
PMID:36706583
NCBI chr10:11,033,976...11,078,103
Ensembl chr10:11,034,035...11,078,101
G
Stac
SH3 and cysteine rich domain
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of STAC mRNA
CTD
PMID:36706583
NCBI chr 8:111,530,800...111,653,228
Ensembl chr 8:111,530,800...111,654,008
G
Stoml3
stomatin like 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of STOML3 mRNA
CTD
PMID:36706583
NCBI chr 2:137,572,691...137,582,402
Ensembl chr 2:137,572,691...137,590,681
G
Strc
stereocilin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of STRC mRNA
CTD
PMID:36706583
NCBI chr 3:108,335,920...108,355,114
Ensembl chr 3:108,335,747...108,354,134
G
Tbr1
T-box brain transcription factor 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TBR1 mRNA
CTD
PMID:36706583
NCBI chr 3:46,350,237...46,368,397
Ensembl chr 3:46,351,213...46,361,041
G
Tekt3
tektin 3
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TEKT3 mRNA
CTD
PMID:36706583
NCBI chr10:47,729,635...47,763,589
Ensembl chr10:47,729,635...47,763,588
G
Tf
transferrin
multiple interactions
ISO
[ferric pyrophosphate co-treated with Iodine] results in increased expression of TF protein
CTD
PMID:16772442
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tfrc
transferrin receptor
multiple interactions
ISO
[ferric pyrophosphate co-treated with Iodine] results in increased expression of TFRC protein
CTD
PMID:16772442
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tg
thyroglobulin
increases expression
ISO
Iodine results in increased expression of TG protein
CTD
PMID:37598415
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
G
Thbs1
thrombospondin 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of THBS1 mRNA
CTD
PMID:36706583
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thra
thyroid hormone receptor alpha
increases expression multiple interactions
ISO
Iodine results in increased expression of THRA mRNA Selenium inhibits the reaction [Iodine results in increased expression of THRA mRNA]
CTD
PMID:17555094
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Thrb
thyroid hormone receptor beta
increases expression multiple interactions
ISO
Iodine results in increased expression of THRB mRNA Selenium inhibits the reaction [Iodine results in increased expression of THRB mRNA]
CTD
PMID:17555094
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Tjp1
tight junction protein 1
multiple interactions
ISO
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Iodine results in increased expression of and results in increased localization of TJP1 protein
CTD
PMID:16514648
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr1
toll-like receptor 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of TLR1 mRNA
CTD
PMID:36706583
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr5
toll-like receptor 5
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of TLR5 mRNA
CTD
PMID:36706583
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
G
Tmem252
transmembrane protein 252
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TMEM252 mRNA
CTD
PMID:36706583
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
G
Tmem72
transmembrane protein 72
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TMEM72 mRNA
CTD
PMID:36706583
NCBI chr 4:149,946,296...149,973,550
Ensembl chr 4:149,948,257...149,973,550
G
Tmem82
transmembrane protein 82
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of TMEM82 mRNA
CTD
PMID:36706583
NCBI chr 5:153,927,486...153,931,942
Ensembl chr 5:153,927,471...153,936,979
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO
Iodine inhibits the reaction [Mustard Gas results in increased expression of TNF protein] Iodine results in increased expression of TNF protein
CTD
PMID:16001271 PMID:37598415
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnnt1
troponin T1, slow skeletal type
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TNNT1 mRNA
CTD
PMID:36706583
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
G
Tnxb
tenascin XB
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of TNXB mRNA
CTD
PMID:36706583
G
Tp63
tumor protein p63
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRP63 mRNA
CTD
PMID:36706583
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Trabd2b
TraB domain containing 2B
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRABD2B mRNA
CTD
PMID:36706583
NCBI chr 5:127,941,198...128,158,946
Ensembl chr 5:127,941,114...128,143,747
G
Traf1
TNF receptor-associated factor 1
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRAF1 mRNA
CTD
PMID:36706583
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf3ip2
Traf3 interacting protein 2
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRAF3IP2 mRNA
CTD
PMID:36706583
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions increases secretion affects abundance
ISO EXP
efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]; Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]]; sodium perchlorate inhibits the reaction [Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]] [Iodine deficiency co-treated with sodium perchlorate] results in increased secretion of TSHB protein Iodine deficiency results in increased secretion of TSHB protein
CTD
PMID:16030158 PMID:20882593 PMID:30090431
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Ttr
transthyretin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TTR mRNA
CTD
PMID:36706583
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Tuba8
tubulin, alpha 8
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TUBA8 mRNA
CTD
PMID:36706583
NCBI chr 4:154,440,045...154,456,918
Ensembl chr 4:154,440,074...154,456,917
G
Ucma
upper zone of growth plate and cartilage matrix associated
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of UCMA mRNA
CTD
PMID:36706583
NCBI chr17:73,293,977...73,303,709
Ensembl chr17:73,293,978...73,303,611
G
Unc5cl
unc-5 family C-terminal like
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of UNC5CL mRNA
CTD
PMID:36706583
NCBI chr 9:12,528,109...12,543,382
Ensembl chr 9:12,528,246...12,542,233
G
Ush1c
USH1 protein network component harmonin
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1C mRNA
CTD
PMID:36706583
NCBI chr 1:96,695,303...96,743,671
Ensembl chr 1:96,695,307...96,743,671
G
Ush1g
USH1 protein network component sans
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1G mRNA
CTD
PMID:36706583
NCBI chr10:100,559,721...100,563,590
Ensembl chr10:100,557,629...100,563,590
G
Vip
vasoactive intestinal peptide
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of VIP mRNA
CTD
PMID:36706583
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Wnt9a
Wnt family member 9A
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of WNT9A mRNA
CTD
PMID:36706583
NCBI chr10:44,094,140...44,121,134
Ensembl chr10:44,094,140...44,121,133
G
Yy2
YY2 transcription factor
multiple interactions
ISO
[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of YY2 mRNA
CTD
PMID:36706583
NCBI chr X:37,438,425...37,442,047
Ensembl chr X:37,410,811...37,464,430
G
Ache
acetylcholinesterase
decreases activity
ISO
Echothiophate Iodide results in decreased activity of ACHE protein
CTD
PMID:16978018
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Alb
albumin
affects binding
ISO
Echothiophate Iodide binds to ALB protein
CTD
PMID:15525694
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Bche
butyrylcholinesterase
decreases activity multiple interactions
ISO
Echothiophate Iodide results in decreased activity of BCHE protein Echothiophate Iodide inhibits the reaction [BCHE protein results in increased hydrolysis of Butyrylthiocholine]
CTD
PMID:7377577 PMID:16213467 PMID:17698511 PMID:21802514
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Nceh1
neutral cholesterol ester hydrolase 1
decreases activity
ISO
Echothiophate Iodide results in decreased activity of NCEH1 protein
CTD
PMID:16978018
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
G
Aass
aminoadipate-semialdehyde synthase
increases expression
EXP
Iodides deficiency results in increased expression of AASS protein
CTD
PMID:26795019
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Actb
actin, beta
decreases expression
EXP
Iodides deficiency results in decreased expression of ACTB protein
CTD
PMID:26795019
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Agxt2
alanine-glyoxylate aminotransferase 2
increases expression
EXP
Iodides deficiency results in increased expression of AGXT2 protein
CTD
PMID:26795019
NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
EXP
Iodides deficiency results in increased expression of AKR1D1 protein
CTD
PMID:26795019
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
increases expression
EXP
Iodides deficiency results in increased expression of ALDH1L1 protein
CTD
PMID:26795019
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
multiple interactions
EXP
[hexabromocyclododecane co-treated with Iodides deficiency] results in decreased expression of ALDH1L2 protein
CTD
PMID:26795019
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Apmap
adipocyte plasma membrane associated protein
decreases expression
EXP
Iodides deficiency results in decreased expression of APMAP protein
CTD
PMID:26795019
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
G
Aqp1
aquaporin 1
affects expression
EXP
Iodides deficiency affects the expression of AQP1 mRNA
CTD
PMID:21623536
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Arg1
arginase 1
increases expression
EXP
Iodides deficiency results in increased expression of ARG1 protein
CTD
PMID:26795019
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Best1
bestrophin 1
multiple interactions increases transport
ISO
PAR-1-activating peptide promotes the reaction [BEST1 protein results in increased transport of Iodides]
CTD
PMID:19828819
NCBI chr 1:206,629,340...206,646,085
Ensembl chr 1:206,629,500...206,646,063
G
Bhmt
betaine-homocysteine S-methyltransferase
multiple interactions
EXP
[hexabromocyclododecane co-treated with Iodides deficiency] results in decreased expression of BHMT protein
CTD
PMID:26795019
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Car3
carbonic anhydrase 3
increases expression
EXP
Iodides deficiency results in increased expression of CA3 protein
CTD
PMID:26795019
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Cftr
CF transmembrane conductance regulator
multiple interactions
ISO
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; 5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]; 5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]; 6-hydroxy-10-chlorobenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]; [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium results in increased activity of CFTR protein] which results in increased expression of Iodides; [[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; Brefeldin A inhibits the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; Brefeldin A inhibits the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]; fenamic acid inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; geldanamycin promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; geldanamycin promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; Glyburide inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]; Thapsigargin promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]; Thapsigargin promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[Colforsin co-treated with Genistein] results in increased transport of Iodides]]]
CTD
PMID:18230692 PMID:18297105
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Cps1
carbamoyl-phosphate synthase 1
increases expression
EXP
Iodides deficiency results in increased expression of CPS1 protein
CTD
PMID:26795019
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Dmgdh
dimethylglycine dehydrogenase
increases expression multiple interactions
EXP
Iodides deficiency results in increased expression of DMGDH protein hexabromocyclododecane inhibits the reaction [Iodides deficiency results in increased expression of DMGDH protein]
CTD
PMID:26795019
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
G
Eno1
enolase 1
multiple interactions
EXP
[hexabromocyclododecane co-treated with Iodides deficiency] results in decreased expression of ENO1 protein
CTD
PMID:26795019
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Etfb
electron transfer flavoprotein subunit beta
decreases expression
EXP
Iodides deficiency results in decreased expression of ETFB protein
CTD
PMID:26795019
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
G
Ethe1
ETHE1, persulfide dioxygenase
increases expression
EXP
Iodides deficiency results in increased expression of ETHE1 protein
CTD
PMID:26795019
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
G
Fdps
farnesyl diphosphate synthase
decreases expression
EXP
Iodides deficiency results in decreased expression of FDPS protein
CTD
PMID:26795019
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Got1
glutamic-oxaloacetic transaminase 1
increases expression
EXP
Iodides deficiency results in increased expression of GOT1 protein
CTD
PMID:26795019
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gsta1
glutathione S-transferase alpha 1
decreases expression
EXP
Iodides deficiency results in decreased expression of GSTA1 protein
CTD
PMID:26795019
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
decreases expression
EXP
Iodides deficiency results in decreased expression of GSTA2 protein
CTD
PMID:26795019
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
decreases expression
EXP
Iodides deficiency results in decreased expression of GSTA3 protein
CTD
PMID:26795019
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gsta4
glutathione S-transferase alpha 4
decreases expression
EXP
Iodides deficiency results in decreased expression of GSTA4 protein
CTD
PMID:26795019
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gstp1
glutathione S-transferase pi 1
decreases expression
EXP
Iodides deficiency results in decreased expression of GSTP1 protein
CTD
PMID:26795019
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstz1
glutathione S-transferase zeta 1
multiple interactions
ISO
Iodides inhibits the reaction [Dichloroacetic Acid results in decreased activity of GSTZ1 protein]
CTD
PMID:24632415
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression
EXP
Iodides deficiency results in decreased expression of HSP90AA1 protein
CTD
PMID:26795019
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa5
heat shock protein family A (Hsp70) member 5
decreases expression
EXP
Iodides deficiency results in decreased expression of HSPA5 protein
CTD
PMID:26795019
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
decreases expression
EXP
Iodides deficiency results in decreased expression of HSPA8 protein
CTD
PMID:26795019
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Iah1
isoamyl acetate hydrolyzing esterase 1
decreases expression
EXP
Iodides deficiency results in decreased expression of IAH1 protein
CTD
PMID:26795019
NCBI chr 6:40,865,530...40,872,747
Ensembl chr 6:40,865,502...40,872,978
G
Lep
leptin
increases expression
EXP
Iodides deficiency results in increased expression of LEP protein
CTD
PMID:26795019
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Nit1
nitrilase 1
increases expression
EXP
Iodides deficiency results in increased expression of NIT1 protein
CTD
PMID:26795019
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
G
Ogdh
oxoglutarate dehydrogenase
increases expression
EXP
Iodides deficiency results in increased expression of OGDH protein
CTD
PMID:26795019
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Pah
phenylalanine hydroxylase
increases expression
EXP
Iodides deficiency results in increased expression of PAH protein
CTD
PMID:26795019
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
G
Pc
pyruvate carboxylase
decreases expression
EXP
Iodides deficiency results in decreased expression of PC protein
CTD
PMID:26795019
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pdia3
protein disulfide isomerase family A, member 3
decreases expression
EXP
Iodides deficiency results in decreased expression of PDIA3 protein
CTD
PMID:26795019
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
Pon3
paraoxonase 3
decreases expression
EXP
Iodides deficiency results in decreased expression of PON3 protein
CTD
PMID:26795019
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Ppia
peptidylprolyl isomerase A
decreases expression
EXP
Iodides deficiency results in decreased expression of PPIA protein
CTD
PMID:26795019
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Qprt
quinolinate phosphoribosyltransferase
decreases expression
EXP
Iodides deficiency results in decreased expression of QPRT protein
CTD
PMID:26795019
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
G
Sardh
sarcosine dehydrogenase
increases expression
EXP
Iodides deficiency results in increased expression of SARDH protein
CTD
PMID:26795019
NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874
G
Scnn1a
sodium channel epithelial 1 subunit alpha
multiple interactions
EXP
Iodides results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein]
CTD
PMID:16027156
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
G
Scnn1b
sodium channel epithelial 1 subunit beta
multiple interactions
EXP
Iodides results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein]
CTD
PMID:16027156
NCBI chr 1:176,430,063...176,484,451
Ensembl chr 1:176,430,103...176,484,451
G
Scnn1g
sodium channel epithelial 1 subunit gamma
multiple interactions
EXP
Iodides results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein]
CTD
PMID:16027156
NCBI chr 1:176,304,942...176,338,816
Ensembl chr 1:176,304,942...176,338,816
G
Slc22a3
solute carrier family 22 member 3
affects expression
EXP
Iodides deficiency affects the expression of SLC22A3 mRNA
CTD
PMID:21623536
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc26a4
solute carrier family 26 member 4
affects transport
ISO
SLC26A4 protein affects the transport of Iodides
CTD
PMID:22116359
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
G
Slc5a5
solute carrier family 5 member 5
multiple interactions affects expression increases uptake
ISO EXP
Dexamethasone promotes the reaction [SLC5A5 protein results in increased uptake of Iodides]; perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodides]; potassium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodides]; thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodides] Iodides deficiency affects the expression of SLC5A5 mRNA
CTD
PMID:15671536 PMID:15850642 PMID:15941870 PMID:16234306 PMID:21623536
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Sult1a1
sulfotransferase family 1A member 1
increases expression
EXP
Iodides deficiency results in increased expression of SULT1A1 protein
CTD
PMID:26795019
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Tf
transferrin
decreases expression
EXP
Iodides deficiency results in decreased expression of TF protein
CTD
PMID:26795019
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tpmt
thiopurine S-methyltransferase
increases expression
EXP
Iodides deficiency results in increased expression of TPMT protein
CTD
PMID:26795019
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
G
Tpo
thyroid peroxidase
increases oxidation
ISO
TPO protein results in increased oxidation of Iodides
CTD
PMID:25595679
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions increases expression
ISO EXP
[Iodides deficiency co-treated with perchlorate] results in increased expression of TSHB protein Iodides deficiency results in increased expression of TSHB protein
CTD
PMID:18178547 PMID:20439182 PMID:26795019
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation multiple interactions
EXP
Potassium Iodide results in increased phosphorylation of AKT1 protein NOX4 protein affects the reaction [Potassium Iodide results in increased phosphorylation of AKT1 protein]; Selenium inhibits the reaction [Potassium Iodide results in increased phosphorylation of AKT1 protein]
CTD
PMID:38013145
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Ar
androgen receptor
decreases expression
EXP
Potassium Iodide results in decreased expression of AR mRNA
CTD
PMID:32593569
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
Potassium Iodide results in increased expression of BAX protein
CTD
PMID:32593569
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
EXP
Potassium Iodide results in decreased expression of BCL2 protein
CTD
PMID:32593569
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
increases expression multiple interactions
ISO
Potassium Iodide results in increased expression of BECN1 mRNA; Potassium Iodide results in increased expression of BECN1 protein 3-methyladenine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 mRNA]; 3-methyladenine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 protein]
CTD
PMID:29923297
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
increases expression
EXP
Potassium Iodide results in increased expression of BID protein
CTD
PMID:32593569
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
EXP
Potassium Iodide results in decreased expression of BIRC5 protein
CTD
PMID:32593569
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Casp3
caspase 3
increases expression
EXP
Potassium Iodide results in increased expression of CASP3 protein
CTD
PMID:32593569
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases expression
EXP
Potassium Iodide results in increased expression of CASP9 protein
CTD
PMID:32593569
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccnd1
cyclin D1
decreases expression
EXP
Potassium Iodide results in decreased expression of CCND1 protein
CTD
PMID:32593569
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdh1
cadherin 1
decreases expression
EXP
Potassium Iodide results in decreased expression of CDH1 protein
CTD
PMID:32593569
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
decreases expression
EXP
Potassium Iodide results in decreased expression of CDH2 protein
CTD
PMID:32593569
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdk4
cyclin-dependent kinase 4
decreases expression
EXP
Potassium Iodide results in decreased expression of CDK4 protein
CTD
PMID:32593569
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cldn1
claudin 1
decreases expression
EXP
Potassium Iodide results in decreased expression of CLDN1 mRNA
CTD
PMID:32593569
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn5
claudin 5
decreases expression
EXP
Potassium Iodide results in decreased expression of CLDN5 mRNA
CTD
PMID:32593569
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Ctnnb1
catenin beta 1
decreases expression
EXP
Potassium Iodide results in decreased expression of CTNNB1 protein
CTD
PMID:32593569
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression
EXP
Potassium Iodide results in decreased expression of CXADR mRNA
CTD
PMID:32593569
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cycs
cytochrome c, somatic
increases expression
EXP
Potassium Iodide results in increased expression of CYCS protein
CTD
PMID:32593569
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
[Sodium Fluoride co-treated with Potassium Iodide] results in increased expression of DDIT3 mRNA; Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of DDIT3 protein] Potassium Iodide results in increased expression of DDIT3 mRNA
CTD
PMID:24231001
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Duox1
dual oxidase 1
multiple interactions
EXP
Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of DUOX1 mRNA]
CTD
PMID:27568464
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duox2
dual oxidase 2
multiple interactions
EXP
Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of DUOX2 mRNA]
CTD
PMID:27568464
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
[Sodium Fluoride co-treated with Potassium Iodide] results in increased expression of ERN1 mRNA; Potassium Iodide promotes the reaction [Sodium Fluoride results in increased expression of ERN1 protein]
CTD
PMID:24231001
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esr1
estrogen receptor 1
multiple interactions
EXP
[bisphenol A co-treated with diisopropanolnitrosamine co-treated with Potassium Iodide] results in increased expression of ESR1 protein; [Potassium Iodide co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein
CTD
PMID:29050248
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
F11r
F11 receptor
decreases expression
EXP
Potassium Iodide results in decreased expression of F11R protein
CTD
PMID:32593569
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
Fn1
fibronectin 1
decreases expression
EXP
Potassium Iodide results in decreased expression of FN1 mRNA
CTD
PMID:32593569
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Foxe1
forkhead box E1
multiple interactions
EXP
[Potassium Iodide co-treated with TSHB protein co-treated with FOXE1 protein] binds to TG promoter; [Potassium Iodide co-treated with TSHB protein co-treated with FOXE1 protein] binds to TPO promoter; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of FOXE1 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of FOXE1 protein]
CTD
PMID:27568464
NCBI chr 5:60,630,027...60,632,835
Ensembl chr 5:60,630,027...60,632,835
G
Fst
follistatin
increases expression
EXP
Potassium Iodide results in increased expression of FST protein
CTD
PMID:32593569
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
G
Gpx1
glutathione peroxidase 1
decreases expression multiple interactions
EXP
Potassium Iodide results in decreased expression of GPX1 mRNA [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Potassium Iodide] results in increased expression of GPX1 mRNA; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of GPX1 mRNA]
CTD
PMID:38013145
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Hmox1
heme oxygenase 1
decreases expression
EXP
Potassium Iodide results in decreased expression of HMOX1 protein
CTD
PMID:32593569
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA]; Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein]
CTD
PMID:24231001
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Itgb1
integrin subunit beta 1
decreases expression
EXP
Potassium Iodide results in decreased expression of ITGB1 protein
CTD
PMID:32593569
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Kit
KIT proto-oncogene receptor tyrosine kinase
decreases expression
EXP
Potassium Iodide results in decreased expression of KIT mRNA; Potassium Iodide results in decreased expression of KIT protein
CTD
PMID:32593569
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Marveld2
MARVEL domain containing 2
decreases expression
EXP
Potassium Iodide results in decreased expression of MARVELD2 protein
CTD
PMID:32593569
NCBI chr 2:31,742,652...31,764,150
Ensembl chr 2:31,657,220...31,764,150
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
EXP
Potassium Iodide results in decreased expression of NFE2L2 protein
CTD
PMID:32593569
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nkx2-1
NK2 homeobox 1
multiple interactions
EXP
[Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to SLC5A5 enhancer; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to TG promoter; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to TPO promoter; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of NKX2-1 mRNA]
CTD
PMID:27568464
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
G
Nox4
NADPH oxidase 4
multiple interactions
EXP
NOX4 protein affects the reaction [Potassium Iodide results in increased phosphorylation of AKT1 protein]
CTD
PMID:38013145
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Ocln
occludin
decreases expression
EXP
Potassium Iodide results in decreased expression of OCLN mRNA
CTD
PMID:32593569
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
multiple interactions
EXP
Potassium Iodide inhibits the reaction [Propylthiouracil results in increased expression of and results in increased activity of ODC1 protein]
CTD
PMID:8882155
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression
EXP
Potassium Iodide results in increased expression of PARP1 protein modified form
CTD
PMID:32593569
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pax8
paired box 8
multiple interactions
EXP
Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to SLC5A5 enhancer]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to SLC5A5 promoter]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to TG promoter]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to TPO promoter]]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of PAX8 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of PAX8 protein]
CTD
PMID:27568464
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
G
Pcna
proliferating cell nuclear antigen
multiple interactions decreases expression
EXP
[Potassium Iodide co-treated with diisopropanolnitrosamine] results in increased expression of PCNA protein Potassium Iodide results in decreased expression of PCNA protein
CTD
PMID:29050248 PMID:32593569
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pten
phosphatase and tensin homolog
decreases expression
EXP
Potassium Iodide results in decreased expression of PTEN mRNA
CTD
PMID:38013145
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression
ISO
Potassium Iodide inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA]; Potassium Iodide inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 protein]; Potassium Iodide inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mRNA] Potassium Iodide results in decreased expression of PTGS2 protein
CTD
PMID:18588940 PMID:19014992
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
decreases expression
EXP
Potassium Iodide results in decreased expression of PTK2 protein; Potassium Iodide results in decreased expression of PTK2 protein modified form
CTD
PMID:32593569
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
multiple interactions decreases expression
EXP
Selenium inhibits the reaction [Potassium Iodide results in decreased expression of PTPN1 mRNA]
CTD
PMID:38013145
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
G
Slc5a5
solute carrier family 5 member 5
multiple interactions decreases expression
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Potassium Iodide results in decreased expression of SLC5A5 mRNA]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Potassium Iodide results in decreased expression of SLC5A5 mRNA]; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to SLC5A5 enhancer; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to SLC5A5 enhancer]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to SLC5A5 promoter]]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of SLC5A5 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of SLC5A5 protein]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of SLC5A5 mRNA]
CTD
PMID:27568464 PMID:38013145
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Sod1
superoxide dismutase 1
increases expression
EXP
Potassium Iodide results in increased expression of SOD1 protein
CTD
PMID:32593569
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
Potassium Iodide inhibits the reaction [monomethylarsonous acid results in increased expression of SOD2 protein]
CTD
PMID:18588940
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sqstm1
sequestosome 1
multiple interactions increases expression
ISO
3-methyladenine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 mRNA]; 3-methyladenine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 protein] Potassium Iodide results in increased expression of SQSTM1 mRNA; Potassium Iodide results in increased expression of SQSTM1 protein
CTD
PMID:29923297
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
ISO
Potassium Iodide inhibits the reaction [monomethylarsonous acid results in increased phosphorylation of SRC protein]
CTD
PMID:18588940
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Testin
testin gene
decreases expression
EXP
Potassium Iodide results in decreased expression of TESTIN mRNA
CTD
PMID:32593569
NCBI chr17:3,824,222...3,859,385
Ensembl chr17:3,846,899...3,859,385
G
Tg
thyroglobulin
multiple interactions
EXP
[Potassium Iodide co-treated with TSHB protein co-treated with FOXE1 protein] binds to TG promoter; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to TG promoter; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to TG promoter]]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TG mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TG protein]
CTD
PMID:27568464
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases expression
EXP
Selenium inhibits the reaction [Potassium Iodide results in increased expression of TGFB1 mRNA]
CTD
PMID:38013145
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tjp1
tight junction protein 1
decreases expression
EXP
Potassium Iodide results in decreased expression of TJP1 mRNA
CTD
PMID:32593569
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tp53
tumor protein p53
increases expression
EXP
Potassium Iodide results in increased expression of TP53 protein
CTD
PMID:32593569
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpo
thyroid peroxidase
multiple interactions
EXP
[Potassium Iodide co-treated with TSHB protein co-treated with FOXE1 protein] binds to TPO promoter; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to TPO promoter; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to TPO promoter]]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TPO mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TPO protein]
CTD
PMID:27568464
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions
EXP
[diisopropanolnitrosamine co-treated with Potassium Iodide] results in increased expression of TSHB protein; [Potassium Iodide co-treated with TSHB protein co-treated with FOXE1 protein] binds to TG promoter; [Potassium Iodide co-treated with TSHB protein co-treated with FOXE1 protein] binds to TPO promoter; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to SLC5A5 enhancer; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to TG promoter; [Potassium Iodide co-treated with TSHB protein co-treated with NKX2-1 protein] binds to TPO promoter; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to SLC5A5 enhancer]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to SLC5A5 promoter]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to TG promoter]]; Potassium Iodide inhibits the reaction [TSHB protein promotes the reaction [PAX8 protein binds to TPO promoter]]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of DUOX1 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of DUOX2 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of FOXE1 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of FOXE1 protein]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of NKX2-1 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of PAX8 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of PAX8 protein]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of SLC5A5 mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of SLC5A5 protein]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TG mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TG protein]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TPO mRNA]; Potassium Iodide inhibits the reaction [TSHB protein results in increased expression of TPO protein]
CTD
PMID:27568464 PMID:29050248
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Txnrd1
thioredoxin reductase 1
multiple interactions decreases expression
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Potassium Iodide results in decreased expression of TXNRD1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of TXNRD1 mRNA]
CTD
PMID:38013145
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Xbp1
X-box binding protein 1
multiple interactions
ISO
Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA]
CTD
PMID:24231001
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Casp3
caspase 3
multiple interactions
EXP
Sodium Iodide promotes the reaction [perchlorate results in increased activity of CASP3 protein]
CTD
PMID:11834455
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cftr
CF transmembrane conductance regulator
affects export
ISO
CFTR protein affects the export of Sodium Iodide
CTD
PMID:14502435
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Iyd
iodotyrosine deiodinase
decreases expression
EXP
Sodium Iodide results in decreased expression of IYD mRNA
CTD
PMID:30814441
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Slc5a5
solute carrier family 5 member 5
multiple interactions increases uptake increases activity increases abundance decreases export
ISO EXP
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid promotes the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; dysidenin inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; mibolerone promotes the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; Ouabain inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; perchlorate inhibits the reaction [mibolerone promotes the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]]; perchlorate inhibits the reaction [SLC5A5 protein results in increased abundance of Sodium Iodide]; perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; perrhenate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; potassium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; sodium bromide inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; sodium chlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; Sodium Iodide inhibits the reaction [SLC5A5 protein results in increased uptake of perrhenate analog]; Sodium Iodide inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Pertechnetate Tc 99m]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog] Sodium Iodide results in increased activity of SLC5A5 protein SLC5A5 protein results in decreased export of Sodium Iodide
CTD
PMID:12488351 PMID:12489024 PMID:12541134 PMID:12601449 PMID:14633711 PMID:15347726 PMID:15520214 PMID:15522214 PMID:16987991 PMID:17611400 More...
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Tpo
thyroid peroxidase
multiple interactions
ISO
Sodium Iodide inhibits the reaction [Methimazole results in decreased activity of TPO protein]
CTD
PMID:7626075
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all